Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersNovel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesNon-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening TrialProstate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.Aspirin and urologic cancer risk: an update.Environmental non-occupational risk factors associated with bladder cancer.Non-steroidal anti-inflammatory drugs use is associated with reduced risk of inflammation-associated cancers: NIH-AARP studyUse of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studiesPrognostic role of NLR in urinary cancers: a meta-analysisThe pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinomaCan daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resectionPrevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis.NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of AgeLong-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study.Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysisA Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma.Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K.Nonsteroidal anti-inflammatory drugs and other analgesic use and bladder cancer in northern New England.The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line.Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer.Attributable causes of cancer in China.Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea.Arsenic Promotes the COX2/PGE2-SOX2 Axis to Increase the Malignant Stemness Properties of Urothelial Cells.Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
P2860
Q26739665-139B1D11-B91F-4A20-A5EF-7DF660218E2EQ28550876-010F69C0-CD3F-41DB-896E-8A0CB94C3E7CQ28551492-9A2AD2C3-BB68-4E0C-B2FE-A15E952F3D37Q34283636-66571F58-8223-4ADC-92AA-502399D30B7EQ34635300-D0A5018D-A0D6-40C6-B4A1-67952AEC8E13Q34650875-BF84B3AD-CD34-4E2B-BC8E-9719B5F4F9D2Q34797536-8BF13512-292B-4F39-95DA-D5CFBC299746Q34875118-BEF90814-17CB-436E-A16F-1F472E2D03D4Q35124106-F89990E1-9930-4ACC-AF1C-516B97E7D4A9Q35144019-163C7B68-D712-4378-9FAE-F0E36C72261CQ35204387-5FAE1B4B-0A3B-4EC2-A860-1F43E59393A9Q35251869-91C634F3-3E17-4FF2-8488-023D5FA1AD34Q35905788-49202B36-2E88-4730-BD96-969B15089B9CQ36017220-D2603E1E-9318-424B-BFDA-60CD4679ADE0Q36232504-DC522B13-3789-4B77-B75F-38E901B1EC81Q36385997-3274CE9D-B66E-4390-9BCF-941E570D37CAQ36468046-9F71D736-C540-4885-AE73-D759A65C73BBQ36542246-50E3D4AC-A37F-46DD-9769-A70D0DBCF5D9Q37053781-9B35A6C5-13AB-4B47-9D35-9499E9B12103Q37584843-D7C1008C-D1FD-4BBF-BF1C-397DCE45DF20Q37607199-079E3305-57AF-4991-87CC-61412E2CE477Q37632955-CFA4F93A-B580-4A85-A1C2-0984FB7D13B2Q39147858-8B512786-A341-43CB-829C-0E1B80617156Q39755154-AE98CEB5-E720-4C5E-982A-56D199B1AA33Q44376865-003A8F4B-B058-4D6F-8582-0E098A471DC0Q47105389-3B63BE62-5AD3-4250-813E-75ADAF8CD33DQ47695974-DE50D87B-E442-4C1F-B403-90F7ADEBAD2AQ48111489-85E5573E-272C-45D2-8941-4530A030736DQ55312563-5FAF8E4E-109B-4CE0-B194-1EDB7F5DF030
P2860
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@ast
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@en
type
label
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@ast
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@en
prefLabel
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@ast
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@en
P2093
P2860
P50
P356
P1476
Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis
@en
P2093
Albert R Hollenbeck
Alice J Sigurdson
Debra T Silverman
Ruth M Pfeiffer
Sarah E Daugherty
P2860
P304
P356
10.1093/AJE/KWQ437
P407
P577
2011-03-02T00:00:00Z